Currently, there are 145.71M common shares owned by the public and among those 123.19M shares have been available to trade.
The company’s stock has a 5-day price change of -18.74% and 57.98% over the past three months. ORGN shares are trading -6.71% year to date (YTD), with the 12-month market performance down to -81.69% lower. It has a 12-month low price of $0.44 and touched a high of $4.53 over the same period. ORGN has an average intraday trading volume of 2.38 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -20.79%, -19.19%, and -7.62% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Origin Materials Inc (NASDAQ: ORGN) shares accounts for 22.64% of the company’s 145.71M shares outstanding.
It has a market capitalization of $114.69M and a beta (3y monthly) value of 0.93. The earnings-per-share (ttm) stands at -$0.00. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.46% over the week and 10.10% over the month.
Earnings per share for the fiscal year are expected to decrease by -35.48%, and 9.09% over the next financial year.
Looking at the support for the ORGN, a number of firms have released research notes about the stock. Craig Hallum stated their Hold rating for the stock in a research note on August 11, 2023, with the firm’s price target at $2. Credit Suisse coverage for the Origin Materials Inc (ORGN) stock in a research note released on October 14, 2022 offered a Outperform rating with a price target of $7. BofA Securities was of a view on January 06, 2022 that the stock is Buy, while HSBC Securities gave the stock Buy rating on November 23, 2021, issuing a price target of $15. BofA Securities on their part issued Neutral rating on October 05, 2021.
